Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$0.28 - $1.16 $241 - $1,002
-864 Reduced 3.38%
24,712 $8,000
Q1 2024

May 14, 2024

BUY
$1.06 - $1.67 $10,279 - $16,195
9,698 Added 61.08%
25,576 $29,000
Q4 2023

Feb 13, 2024

BUY
$1.26 - $1.79 $19,628 - $27,884
15,578 Added 5192.67%
15,878 $26,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $26,779 - $45,807
-23,491 Reduced 98.74%
300 $0
Q1 2023

May 12, 2023

BUY
$1.2 - $2.19 $9,504 - $17,344
7,920 Added 49.9%
23,791 $31,000
Q4 2022

Feb 14, 2023

BUY
$1.63 - $3.52 $25,869 - $55,865
15,871 New
15,871 $26,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.